Back to DE D. E. Shaw & Co., Inc.
AXSM
Showing 8 of 25 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Axsome Therapeutics, Inc.
Yes. D. E. Shaw holds 604,753 shares of AXSM (Axsome Therapeutics), worth $148M, as of its Q2 2026 13F filing. It increased the position by 1,288 shares (+0.2%) from Q1 2026. D. E. Shaw has held AXSM since Q4 2023, across 11 quarterly 13F filings. AXSM is 0.1% of D. E. Shaw's reported 13F portfolio.
Current Value
$148M
Current Shares
604,753
Total Value Change
+$147.8M
Total Shares Change
+601,853
Quarter-by-Quarter History